Bay Colony Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Hold |
1,572
| – | – | 0.09% | 204 |
|
|
2025
Q1 | $786K | Sell |
1,572
-36
| -2% | -$18K | 0.12% | 172 |
|
|
2024
Q4 | $837K | Sell |
1,608
-821
| -34% | -$427K | 0.12% | 169 |
|
|
2024
Q3 | $1.5M | Buy |
2,429
+20
| +0.8% | +$12.4K | 0.23% | 102 |
|
|
2024
Q2 | $1.33M | Sell |
2,409
-22
| -0.9% | -$12.2K | 0.22% | 94 |
|
|
2024
Q1 | $1.41M | Buy |
2,431
+323
| +15% | +$188K | 0.25% | 85 |
|
|
2023
Q4 | $1.12M | Buy |
2,108
+348
| +20% | +$185K | 0.22% | 100 |
|
|
2023
Q3 | $891K | Buy |
1,760
+301
| +21% | +$152K | 0.21% | 109 |
|
|
2023
Q2 | $761K | Buy |
1,459
+163
| +13% | +$85K | 0.18% | 119 |
|
|
2023
Q1 | $730K | Buy |
1,296
+39
| +3% | +$22K | 0.19% | 119 |
|
|
2022
Q4 | $692K | Buy |
1,257
+70
| +6% | +$38.6K | 0.18% | 133 |
|
|
2022
Q3 | $602K | Sell |
1,187
-20
| -2% | -$10.1K | 0.18% | 129 |
|
|
2022
Q2 | $722K | Buy |
1,207
+91
| +8% | +$54.4K | 0.18% | 126 |
|
|
2022
Q1 | $659K | Buy |
1,116
+190
| +21% | +$112K | 0.16% | 144 |
|
|
2021
Q4 | $618K | Buy |
926
+11
| +1% | +$7.34K | 0.18% | 141 |
|
|
2021
Q3 | $523K | Buy |
915
+13
| +1% | +$7.43K | 0.17% | 159 |
|
|
2021
Q2 | $455K | Sell |
902
-5
| -0.6% | -$2.52K | 0.15% | 183 |
|
|
2021
Q1 | $414K | Buy |
907
+40
| +5% | +$18.3K | 0.16% | 172 |
|
|
2020
Q4 | $404K | Buy |
867
+72
| +9% | +$33.6K | 0.21% | 143 |
|
|
2020
Q3 | $351K | Buy |
+795
| New | +$351K | 0.22% | 146 |
|
|
2018
Q3 | – | Sell |
-287
| Closed | -$59K | – | 833 |
|
|
2018
Q2 | $59K | Buy |
+287
| New | +$59K | 0.04% | 345 |
|